PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421803
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421803
The global photomedicine market size is expected to reach USD 9,682.15 million by 2032, according to a new study by Polaris Market Research. The report "Photomedicine Market Share, Size, Trends, Industry Analysis Report, By Type (Light Emitting Diodes, Lasers, Full Spectrum Light, Polychromatic Polarized Light, Dichroic Lamps, Fluorescent Lamps); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growth of the photomedicine market is primarily propelled by heightened aesthetic consciousness and advancements in laser treatments. Factors such as an increase in skin damage occurrences, shifts in lifestyle, a surge in the preference for noninvasive procedures, and a growing demand for aesthetic enhancements like skin resurfacing and laser hair removal, particularly among women for beautification, contribute significantly to market expansion. The younger and older demographics alike are becoming more aware of beauty and wellness, with older people seeking to retain a youthful appearance.
Photomedicine products offer minimally invasive yet effective aesthetic solutions, driving their demand. Consequently, numerous companies are developing and gaining regulatory approvals for these products, which are applicable in diverse aesthetic procedures, including hair and tattoo removal. Hence, aesthetic enhancement plays a pivotal role in propelling the growth of the photomedicine market.
Moreover, the growing incidence of vision-related problems attributed to natural factors like extended use of television and computer screens or head injuries contributes to the increasing significance of ophthalmological issues. Furthermore, the prevalence of dermatological conditions, including acne and psoriasis, a rise in dental procedures, and an escalating demand for pain management therapies all collectively contribute to the expansion of the market. Nevertheless, the availability of alternative treatment options and concerns regarding the safety of photomedicine devices are expected to serve as restraining factors for market growth.
Additionally, emerging nations offer substantial growth opportunities for the photomedicine market due to improved healthcare accessibility, escalating disposable incomes, and an expanding pool of potential patients. Moreover, there is a surge in medical tourism for advanced treatments such as transplants, cancer therapies, and cosmetic procedures in these regions. Both residents and visiting patients contribute to the increasing utilization of photomedicine. It presents companies with significant prospects to tap into these high-potential markets.
In 2022, the laser segment held the largest market on account of the increasing popularity of lasers in cosmetic and aesthetic procedures.
The ophthalmology segment is expected to witness the fastest growth during the forecast period, which is mainly driven by the aging population and technological advancements.
In 2022, the hospital segment held a significant revenue share, mainly due to growth in technology.
North America held the largest market share in 2022, owing to advanced healthcare infrastructure and extensive research and development initiatives.
The global key market players include: BIOLASE, Inc., Ellex Medical Lasers Ltd., Fotona, Lumenis Ltd, Fotona, Lumibird, etc.
Polaris Market Research has segmented the photomedicine market report based on type, application, end-Use, and region: